Mr. Speaker, that is an important question that highlights and underscores our made-in-Canada initiative for investing in Canadian ingenuity and creativity, and supports our scientists and researchers. I am proud to say that we made significant investments in therapeutics and vaccine initiatives here in Canada. For example, from Vancouver, AbCellera received our support, as well as Medicago from Quebec City. We also invested in VBI in Ottawa and, of course, in Saskatoon through VIDO-InterVac and Dartmouth's IMV.
Those are some examples of made-in-Canada solutions that we have come forward with.